Similarly, for ovarian cancer (OC), the risk of development in healthy individuals is estimated to be 1–2%, while in BRCA2-positive individuals, it increases to 39–44%, with a greater impact for BRCA1 variants (11–17%) [6]. Here, BRCA2 is linked to ovarian carcinoma.